Venture Capital

Axial Therapeutics welcomes Sarah Meibusch, Dr. Mark Ohori and Nora Frey to its Board along with raising $37m Series C financing led by OneVentures and UTokyo IPC

– USA, MA –  Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases, today announced a $37.25 million Series C financing led by OneVentures and UTokyo IPC (University of Tokyo Innovation Platform Company) alongside Autism Impact Fund and Corundum Systems Biology and existing investors, Longwood Fund, Seventure Partners, Taiho Ventures, and Domain Associates also participating in this round.…

TreeFrog Therapeutics raises $75m Series B financing led by Bpifrance and announces Dr. Frederic Desdouits as CEO alongside Laurent Higueret and Peter Zippelius joining the Board of Directors

– FRANCE, Bordeaux –  TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, today announced the successful closing of a $75m Series B financing round led by Bpifrance Large Venture alongside Leonard Green & Partners L.P.,

…

Attralus welcomes Dr. Alex Denner to its Board and announces $116m Series B financing led by Logos Capital

– USA, CA –  Attralus, Inc., a clinical-stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced that it has closed a $116 million Series B financing round led by Logos Capital alongside Janus Henderson Investors, Redmile Group, Samsara BioCapital, Sarissa Capital Management, Surveyor Capital, Vivo Capital, and founding investor, venBio Partners, also participating.…